Senior insider sale
President and CEO at ADMA BIOLOGICS, INC. — senior position signals high conviction
$1.65M
105K shares
What this filing means
GROSSMAN ADAM S plans to sell 105K shares of ADMA BIOLOGICS, INC. valued at approximately $1.65M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/24/2025ACC: 0001140361-25-039330
DirectorOfficer· President and CEO
Since Feb 2026
105K
Shares to sell
$1.65M
Approx. market value
63K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Stock Option Exercise - Options
Cash
10/24/2025
45KRestricted Stock Units vesting - granted March 6, 2023
Compensatory payment
3/6/2025
18KTotal acquired63K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/24/2025 | Stock Option Exercise - Options Cash | 45K | — |
3/6/2025 | Restricted Stock Units vesting - granted March 6, 2023 Compensatory payment | 18K | — |
| Total | 63K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
21K
Market value
$338.7K
9/15/2025
—Completed
Units to sell
21K
Market value
$354.5K
8/15/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
63K
Market value
$960.8K
10/24/2025
Total
Units
105K
Value
$1.65M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/15/2025 | 21K | $338.7K | — | Completed |
8/15/2025 | 21K | $354.5K | — | Completed |
| Planned — Approximate Date | ||||
10/24/2025 | 63K | $960.8K | NASDAQ | Planned |
| Total | 105K | $1.65M | ||